
Reviewers at the agency said there was limited clinical evidence and human trials supporting peptides, sharply diverging with US health chief Robert F. Kennedy's plan to deregulate them.
US FDA staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in stark contrast to Health Secretary Robert F. Kennedy, Jr., who has publicly endorsed the compounds and said he is a “big fan.”
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.
Join thousands of readers who get XOTLIST delivered daily. No spam, ever. Unsubscribe anytime.